Seneca Therapeutics: Funding, Investors & Team (Sep 2026)
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.
Seneca Therapeutics has raised $11.6M across 2 funding rounds on record, the most recent a Series B of $3.9M announced in Aug 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Seneca Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Seneca Therapeutics Funding Rounds
Seneca Therapeutics raised $7.7M in an undisclosed round announced in Jan 2023.
2.6 years later, a Series B of $3.9M was announced in Aug 2025.
Seneca Therapeutics Founders and Leadership Team
Contact details for the Seneca Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Seneca Therapeutics Funding Compared to Other Biotechnology Startups
Seneca Therapeutics' latest round of $3.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Seneca Therapeutics in Biotechnology and Blue Bell
Companies Similar to Seneca Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Seneca Therapeutics Funding FAQs
What does Seneca Therapeutics do?
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.
How much funding has Seneca Therapeutics raised?
Seneca Therapeutics has raised $11.6M across 2 rounds on record. The most recent is a Series B of $3.9M announced in Aug 2025.
When did Seneca Therapeutics last raise funding?
Seneca Therapeutics' most recent funding round on record is a Series B of $3.9M, announced in Aug 2025.
Who founded Seneca Therapeutics?
FundedIQ lists Paul Hallenbeck (Founder) at Seneca Therapeutics.
Where is Seneca Therapeutics headquartered?
Seneca Therapeutics is based in Blue Bell, Pennsylvania, United States.
How many employees does Seneca Therapeutics have?
Seneca Therapeutics is in the 11-50 employee band.
How does Seneca Therapeutics' funding compare to other Biotechnology startups?
Seneca Therapeutics' latest round of $3.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Seneca Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Seneca Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.